Chronically Established ρ0 Cancer Cells Exhibit Shared Stemness-Associated and Aggressive Phenotypes Across Multiple Cancer Cell Lines.

IF 3.4 3区 医学 Q2 ONCOLOGY
Journal of Cancer Pub Date : 2026-09-03 eCollection Date: 2026-01-01 DOI:10.7150/jca.138124
Yu-Seon Han, Myeong-Eun Jegal, Su Yeon Lee, Joung-Sun Park, Yung-Jin Kim
{"title":"Chronically Established ρ<sup>0</sup> Cancer Cells Exhibit Shared Stemness-Associated and Aggressive Phenotypes Across Multiple Cancer Cell Lines.","authors":"Yu-Seon Han, Myeong-Eun Jegal, Su Yeon Lee, Joung-Sun Park, Yung-Jin Kim","doi":"10.7150/jca.138124","DOIUrl":null,"url":null,"abstract":"<p><p>Chronically established mitochondrial DNA-depleted (ρ<sup>0</sup>) cancer cells may exhibit phenotypic changes beyond metabolic dysfunction; however, whether such changes are shared across different cancer types remains unclear. In this study, we generated chronically established ρ<sup>0</sup> models from pancreatic, lung, and breast cancer cell lines and examined their common phenotypic features. Compared with their parental wild-type counterparts, the ρ<sup>0</sup> cell lines exhibited increased proliferation, chemoresistance-related features, sphere-forming ability, wound closure, invasion-related phenotypes, and angiogenic activity, together with common morphological alterations. These changes were accompanied by VDAC1 upregulation and cytoskeletal remodeling. Pharmacologic treatment with VBIT-4 attenuated several of these phenotypes, whereas its effects on chemoresistance-related responses varied across cell lines. Collectively, these findings suggest that chronically established ρ<sup>0</sup> cancer cells exhibit shared stemness-associated and aggressive phenotypes across multiple cancer cell lines, accompanied by VDAC1 upregulation and cytoskeletal remodeling.</p>","PeriodicalId":15183,"journal":{"name":"Journal of Cancer","volume":"17 9","pages":"1615-1625"},"PeriodicalIF":3.4000,"publicationDate":"2026-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13573307/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.7150/jca.138124","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Chronically established mitochondrial DNA-depleted (ρ0) cancer cells may exhibit phenotypic changes beyond metabolic dysfunction; however, whether such changes are shared across different cancer types remains unclear. In this study, we generated chronically established ρ0 models from pancreatic, lung, and breast cancer cell lines and examined their common phenotypic features. Compared with their parental wild-type counterparts, the ρ0 cell lines exhibited increased proliferation, chemoresistance-related features, sphere-forming ability, wound closure, invasion-related phenotypes, and angiogenic activity, together with common morphological alterations. These changes were accompanied by VDAC1 upregulation and cytoskeletal remodeling. Pharmacologic treatment with VBIT-4 attenuated several of these phenotypes, whereas its effects on chemoresistance-related responses varied across cell lines. Collectively, these findings suggest that chronically established ρ0 cancer cells exhibit shared stemness-associated and aggressive phenotypes across multiple cancer cell lines, accompanied by VDAC1 upregulation and cytoskeletal remodeling.

长期建立的ρ0癌细胞在多个癌细胞系中表现出共享的干细胞相关和侵袭性表型。
长期建立的线粒体dna缺失(ρ0)癌细胞可能表现出代谢功能障碍以外的表型变化;然而,这些变化是否在不同类型的癌症中共享仍不清楚。在这项研究中,我们从胰腺癌、肺癌和乳腺癌细胞系中建立了长期建立的ρ0模型,并检测了它们的共同表型特征。与亲本野生型相比,ρ0细胞系表现出增殖、化学抗性相关特征、成球能力、伤口愈合、入侵相关表型和血管生成活性增加,以及常见的形态学改变。这些变化伴随着VDAC1上调和细胞骨架重塑。用VBIT-4进行药物治疗可以减轻其中的几种表型,但其对化学耐药相关反应的影响在不同细胞系中有所不同。总的来说,这些发现表明,长期建立的ρ0癌细胞在多个癌细胞系中表现出共同的干细胞相关和侵袭性表型,并伴有VDAC1上调和细胞骨架重塑。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Cancer
Journal of Cancer ONCOLOGY-
CiteScore
8.10
自引率
2.60%
发文量
333
审稿时长
12 weeks
期刊介绍: Journal of Cancer is an open access, peer-reviewed journal with broad scope covering all areas of cancer research, especially novel concepts, new methods, new regimens, new therapeutic agents, and alternative approaches for early detection and intervention of cancer. The Journal is supported by an international editorial board consisting of a distinguished team of cancer researchers. Journal of Cancer aims at rapid publication of high quality results in cancer research while maintaining rigorous peer-review process.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书